JINWOOK SEO,JONG MUN SON,SANG HOON PAIK,THONG-GYU JIN,YO KYUNG CHUNG,YONG WOON CHOI,YONG-CHUL KIM,YOO CHANG PARK
申请号：
BR112013032193
公开号：
BR112013032193A2
申请日:
2012.06.15
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
Disclosed is a composition comprising recombinant iduronate-2-sulfatase (IDS). The glycosylation pattern and formylglycine content of the IDS composition are different from those of Elaprase and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.
